Tesamorelin holds FDA approval for HIV-associated lipodystrophy based on two Phase 3 RCTs (Falutz et al., 2007 and 2010) showing roughly 15 to 18 percent visceral adipose tissue reduction versus placebo at 26 weeks
The Scale Lies: Why the Number on the Scale is Misleading Health is more than just the number on the scale
Most patients notice visible improvement within a few days, with the best results appearing in about a week
Available as: Last cited 6 Sept 2023 Urva S, OFarrell L, Du Y, Loh MT, Hemmingway A, Qu H, Alsina-Fernandez J, Haupt A, Milicevic Z, Coskun T (2023) The novel GIP, GLP-1 and glucagon receptor agonist retatrutide delays gastric emptying
Always follow your prescriber's guidance
Mercodia GLP-1 (9-36) Amide Control Low, Medium, High (10-1287-01) is a three-level control for the Mercodia Total GLP-1 ELISA